11 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33604804 | Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study. | 2021 Mar | 3 |
2 | 34160790 | Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study. | 2021 Jul | 1 |
3 | 34866875 | Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study. | 2021 Nov | 1 |
4 | 32313609 | Glargine-300: An updated literature review on randomized controlled trials and real-world studies. | 2020 Apr 15 | 1 |
5 | 32315508 | Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues. | 2020 Apr 21 | 2 |
6 | 32337298 | Switching from Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study. | 2020 | 1 |
7 | 32729217 | A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study. | 2020 Nov | 1 |
8 | 32753920 | Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland. | 2020 | 1 |
9 | 32928792 | Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial. | 2020 Sep | 2 |
10 | 31144445 | Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study. | 2019 Sep | 1 |
11 | 31487242 | [New generation of insulins: glargine U300. Summary of clinical evidence]. | 2019 | 2 |